Business Context and Reporting Period
This Form 8-K is a current report filed by BioSig Technologies, Inc. (not Streamex Corp.) on September 10, 2018. The filing reports a material corporate action regarding the company's capital structure and stockholder rights.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on corporate governance and equity structure changes.
Material Changes
- Reverse Stock Split: The Board approved a 1-for-2.5 reverse stock split of issued and outstanding common stock.
- Effective Date: The split became effective at 5:00 p.m. Eastern Time on September 10, 2018.
- Trading Adjustments: Common stock began trading on a split-adjusted basis on September 11, 2018.
- Symbol Change: The OTCQB trading symbol temporarily changed to "BSGMD" for 20 business days before reverting to "BSGM".
- CUSIP Update: The new CUSIP number for common stock is 09073N 201.
- Equity Adjustments: Proportionate adjustments were made to the exercise prices and share counts for outstanding preferred stock, options, restricted stock units, and warrants. Fractional shares were rounded up to the nearest whole share.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management outlook, or specific risk factors beyond the operational details of the reverse stock split. The primary purpose is to disclose the amendment to the Certificate of Incorporation and the resulting change in the rights of security holders.
Investor Verification Checklist
- Verify the new CUSIP number (09073N 201) for trading and settlement purposes.
- Confirm the temporary trading symbol "BSGMD" and the timeline for its reversion to "BSGM".
- Check the adjusted exercise prices and share quantities for any held stock options, warrants, or convertible securities.
- Review the definitive proxy statement filed on June 20, 2018, for additional details on the authorization process.